Active - does not include patients

Heart Failure with Preserved Ejection Fraction (MRA Study)

Location: Solmed Polyclinic (Zagreb), SB Medico (Rijeka)

Study Drug: Mineralocorticoid receptor antagonist, already registered for the treatment of other diseases.

Main Inclusion Criteria: Adult patients recently discharged from the hospital due to heart failure with an ejection fraction >40%.

Status: In preparation

Start of Patient Enrollment: August 2024

Testimonials from
our patients

Newsletter

Receive regular notifications about our activities and news in treatments.

Free examinations